{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T08:35:02Z","timestamp":1778661302119,"version":"3.51.4"},"reference-count":16,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.intimp.2015.09.023","type":"journal-article","created":{"date-parts":[[2015,10,2]],"date-time":"2015-10-02T03:50:35Z","timestamp":1443757835000},"page":"964-965","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Intravenous immunoglobulin treatment in a HIV-1 positive patient with Guillain-Barr\u00e9 syndrome"],"prefix":"10.1016","volume":"29","author":[{"given":"Elena Cecilia","family":"Rosca","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ovidiu","family":"Rosca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mihaela","family":"Simu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2015.09.023_bb0005","first-page":"1128","article-title":"High dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood","volume":"1","author":"Imbach","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2015.09.023_bb0010","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1056\/NEJMra1009433","article-title":"Intravenous immune globulin in autoimmune and inflammatory diseases","volume":"367","author":"Gelfand","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2015.09.023_bb0015","first-page":"80","article-title":"Neurological complications of the gay immunosuppressed syndrome: clinical and pathological features","volume":"12","author":"Britton","year":"1982","journal-title":"Ann. Neurol."},{"issue":"6","key":"10.1016\/j.intimp.2015.09.023_bb0020","doi-asserted-by":"crossref","first-page":"591","DOI":"10.3109\/00365548609021668","article-title":"Guillain-Barr\u00e9 syndrome as an early manifestation of HIV central nervous system infection","volume":"18","author":"Hagberg","year":"1986","journal-title":"Scand. J. Infect. Dis."},{"issue":"1\u20132","key":"10.1016\/j.intimp.2015.09.023_bb0025","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0022-510X(02)00418-5","article-title":"HIV-associated Guillain-Barr\u00e9 syndrome","volume":"208","author":"Brannagan","year":"2003","journal-title":"J. Neurol. Sci."},{"issue":"11","key":"10.1016\/j.intimp.2015.09.023_bb0030","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1097\/00002030-200207260-00017","article-title":"Acute Guillain-Barr\u00e9 syndrome during the chronic phase of HIV infection and dramatic improvement under highly active antiretroviral therapy","volume":"16","author":"Bani-Sadr","year":"2002","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.intimp.2015.09.023_bb0035","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1053\/jinf.2001.0917","article-title":"Recurrent Guillain-Barre syndrome as a complication of immune reconstitution in HIV","volume":"44","author":"Makela","year":"2002","journal-title":"J. Infect."},{"issue":"6","key":"10.1016\/j.intimp.2015.09.023_bb0040","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2165\/00003495-200464060-00003","article-title":"Guillain-Barr\u00e9 syndrome: epidemiology, pathophysiology and management","volume":"64","author":"Kuwabara","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.intimp.2015.09.023_bb0045","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1080\/00365540500277227","article-title":"Temporarily controlled HIV-1 replication after intravenous immunoglobulin treatment of Guillain-Barr\u00e9 syndrome","volume":"37","author":"Gisslen","year":"2005","journal-title":"Scand. J. Infect. Dis."},{"key":"10.1016\/j.intimp.2015.09.023_bb0050","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1001\/jama.1997.03550010072043","article-title":"Acute primary HIV infection","volume":"278","author":"Quinn","year":"1997","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.intimp.2015.09.023_bb0055","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/mus.21465","article-title":"Neuromuscular diseases associated with HIV-1 infection","volume":"40","author":"Robinson-Papp","year":"2009","journal-title":"Muscle Nerve"},{"issue":"1","key":"10.1016\/j.intimp.2015.09.023_bb0060","first-page":"103","article-title":"Guillain Barre syndrome in an HIV-1-infected patient after the beginning of combined antiretroviral therapy: an immune reconstitution inflammatory syndrome?","volume":"37","author":"Fantauzzi","year":"2014","journal-title":"New Microbiol."},{"issue":"4","key":"10.1016\/j.intimp.2015.09.023_bb0065","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jaci.2006.01.015","article-title":"Use of intravenous immunoglobulin in human disease: a review of evidence by members of the primary immunodeficiency committee of American academy of allergy, asthma and immunology","volume":"117","author":"Orange","year":"2006","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.intimp.2015.09.023_bb0070","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1742-6405-6-15","article-title":"Reduction of the HIV-1 reservoir in resting CD4+ T-lymphocytes by high dosage intravenous immunoglobulin treatment: a proof-of-concept study","volume":"6","author":"Lindkvist","year":"2009","journal-title":"AIDS Res. Ther."},{"key":"10.1016\/j.intimp.2015.09.023_bb0075","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1742-6405-8-21","article-title":"Rebound of residual plasma viremia after initial decrease following addition of intravenous immunoglobulin to effective antiretroviral treatment of HIV","volume":"8","author":"Mellberg","year":"2011","journal-title":"AIDS Res. Ther."},{"issue":"10","key":"10.1016\/j.intimp.2015.09.023_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0075199","article-title":"Immune reconstitution treatment alleviates the state of persistent immune activation and suppressed CD4 T cell counts in CVID","volume":"8","author":"Paquin-Proulx","year":"2013","journal-title":"PLoS One"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576915301259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576915301259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T20:28:06Z","timestamp":1537302486000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576915301259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S1567576915301259"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2015.09.023","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravenous immunoglobulin treatment in a HIV-1 positive patient with Guillain-Barr\u00e9 syndrome","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2015.09.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}